Cystatin 13 inhibitors are a class of molecules that target cystatin 13, a member of the cystatin superfamily of cysteine protease inhibitors. Cystatins are known to regulate the activity of cysteine proteases, particularly cathepsins, which are involved in various cellular processes, such as protein degradation, antigen presentation, and intracellular proteolysis. Cystatin 13, specifically, is one of the lesser-known cystatins, and while the detailed biological function of cystatin 13 remains to be fully elucidated, it is believed to play a role in modulating protease activity within specific cellular contexts. Inhibitors of cystatin 13 are designed to interfere with its interaction with cysteine proteases, thus altering the balance of protease activity in the system in which cystatin 13 operates.
The structure of cystatin 13 includes conserved cystatin domains, which are responsible for its binding affinity to target proteases. By inhibiting cystatin 13, these molecules can potentially affect the proteolytic pathways controlled by this protein, leading to shifts in the degradation of intracellular proteins. The precise mechanism by which cystatin 13 inhibitors bind and block its function is an area of active research, and structural studies suggest that inhibitors may mimic natural substrates or occupy the cystatin's active site, preventing it from interacting with its protease targets. These inhibitors are valuable tools for probing the functional roles of cystatin 13 in protease regulation and for understanding its contribution to proteostasis and cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64, a cysteine protease inhibitor, directly hinders cystatin 13 by blocking the active sites of cysteine proteases, essential for the protein's inhibitory function. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Leupeptin, a protease inhibitor, indirectly inhibits cystatin 13 by preventing the degradation of endogenous proteins, altering cellular dynamics and disrupting its regulatory role. | ||||||
Z-FA-FMK | 197855-65-5 | sc-201303 sc-201303A | 1 mg 5 mg | $128.00 $372.00 | 19 | |
Z-FA-FMK, a caspase inhibitor, indirectly impacts cystatin 13 by inhibiting caspase activity, influencing apoptotic pathways and modulating cellular processes involving the target protein. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132, a proteasome inhibitor, indirectly influences cystatin 13 by disrupting the ubiquitin-proteasome system, leading to alterations in protein turnover and cellular regulation. | ||||||
Boc-Asp(OMe)-fluoromethyl ketone | 187389-53-3 | sc-214616 | 5 mg | $681.00 | ||
Boc-D-FMK, a caspase inhibitor, indirectly impacts cystatin 13 by inhibiting caspase activity, influencing apoptotic pathways and modulating cellular processes involving the target protein. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Epoxomicin, a proteasome inhibitor, indirectly influences cystatin 13 by disrupting the ubiquitin-proteasome system, leading to alterations in protein turnover and cellular regulation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, a proteasome inhibitor, indirectly influences cystatin 13 by disrupting the ubiquitin-proteasome system, leading to alterations in protein turnover and cellular regulation. | ||||||